BIOX Stock Overview
Provides crop productivity solutions. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Bioceres Crop Solutions Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$4.24 |
| 52 Week High | US$13.18 |
| 52 Week Low | US$3.69 |
| Beta | 0.60 |
| 1 Month Change | 5.74% |
| 3 Month Change | -33.75% |
| 1 Year Change | -66.93% |
| 3 Year Change | -65.94% |
| 5 Year Change | -13.47% |
| Change since IPO | -13.47% |
Recent News & Updates
Bioceres Crop Solutions' (NASDAQ:BIOX) Weak Earnings May Only Reveal A Part Of The Whole Picture
Mar 07
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Might Not Be As Mispriced As It Looks After Plunging 41%
Mar 05Bioceres Is Approaching Distressed Prices, But I Remain On The Sidelines
Feb 13Recent updates
Bioceres Crop Solutions' (NASDAQ:BIOX) Weak Earnings May Only Reveal A Part Of The Whole Picture
Mar 07Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Might Not Be As Mispriced As It Looks After Plunging 41%
Mar 05Bioceres Is Approaching Distressed Prices, But I Remain On The Sidelines
Feb 13Bioceres Is Getting Cheaper, Not Yet An Opportunity But More Interesting
Nov 13Take Care Before Jumping Onto Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Even Though It's 29% Cheaper
Sep 28
HB4 Wheat's US Approval Sparks Global Expansion And Profit Growth Surge
Sep 18 Approval of HB4 Wheat in the US highlights significant expansion and revenue opportunities, enhancing global acceptance and credibility of HB4 technology.Bioceres' Q4 2024 Shows Challenges With HB4 Rollout, Still A Hold Despite Lower Stock Prices
Sep 17These 4 Measures Indicate That Bioceres Crop Solutions (NASDAQ:BIOX) Is Using Debt Extensively
Aug 03Bioceres Needs To Add Clarity Around Borrowings
Mar 23Bioceres Crop Solutions (NASDAQ:BIOX) Takes On Some Risk With Its Use Of Debt
Feb 03Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?
Oct 04Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Popularity With Investors Is Clear
Jun 21Here's Why Bioceres Crop Solutions (NASDAQ:BIOX) Is Weighed Down By Its Debt Load
May 09Bioceres: A Resilient Small Cap With Conference Appearances After Thursday's Earnings
Sep 06Bioceres Crop Solutions jumps 15% after investor pitch
Aug 23We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt
Apr 10Bioceres Has Not Resolved Its Major Risks And Is Growing Based On Commodities Bullishness
Mar 31Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?
Mar 17Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?
Nov 13Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue
Jul 08Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)
Jun 16What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?
May 26Bioceres partners with Havanna to offer consumers HB4 wheat-based sustainable products
May 10Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?
May 05Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue
Apr 05Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?
Mar 10Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year
Feb 12Shareholder Returns
| BIOX | US Chemicals | US Market | |
|---|---|---|---|
| 7D | -12.4% | -3.6% | -5.6% |
| 1Y | -66.9% | -10.6% | 3.3% |
Return vs Industry: BIOX underperformed the US Chemicals industry which returned -7.5% over the past year.
Return vs Market: BIOX underperformed the US Market which returned 8.4% over the past year.
Price Volatility
| BIOX volatility | |
|---|---|
| BIOX Average Weekly Movement | 11.6% |
| Chemicals Industry Average Movement | 5.6% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.4% |
Stable Share Price: BIOX's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: BIOX's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Transition To Capital-Light Model And Global Expansion Will Shape Future Success
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | Federico Trucco | investors.biocerescrops.com/home/default.aspx |
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
Bioceres Crop Solutions Corp. Fundamentals Summary
| BIOX fundamental statistics | |
|---|---|
| Market cap | US$281.57m |
| Earnings (TTM) | US$1.50m |
| Revenue (TTM) | US$407.73m |
177.2x
P/E Ratio0.7x
P/S RatioIs BIOX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIOX income statement (TTM) | |
|---|---|
| Revenue | US$407.73m |
| Cost of Revenue | US$238.31m |
| Gross Profit | US$169.42m |
| Other Expenses | US$167.92m |
| Earnings | US$1.50m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.024 |
| Gross Margin | 41.55% |
| Net Profit Margin | 0.37% |
| Debt/Equity Ratio | 77.8% |
How did BIOX perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/03 04:29 |
| End of Day Share Price | 2025/04/03 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Bioceres Crop Solutions Corp. is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Brian Kemp Dolliver | Brookline Capital Markets |
| Austin Moeller | Canaccord Genuity |
| Benjamin Klieve | Lake Street Capital Markets, LLC |